Skip to content
10-K

Annual Report

SPRING PHARMACEUTICAL GROUP, INC.

0001096906-18-000372

← back to feed
Filed
Jun 29, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Jun 29, 2018 29.84M sh
Capex FY 2017 · Mar 31, 2018 $2.15M
Capex FY 2017 · Mar 31, 2017 $2.88M
Cash And Equivalents FY 2017 · Mar 31, 2018 $25.35M
Cash And Equivalents FY 2017 · Mar 31, 2017 $10.31M
Cash And Equivalents FY 2017 · Mar 31, 2016 $7.64M
Stockholders Equity FY 2017 · Mar 31, 2018 $105.11M
Stockholders Equity restated FY 2017 · Mar 31, 2017 $84.88M
Current Liabilities FY 2017 · Mar 31, 2018 $1.98M
Current Liabilities FY 2017 · Mar 31, 2017 $2.99M
Current Assets FY 2017 · Mar 31, 2018 $30.07M
Current Assets FY 2017 · Mar 31, 2017 $18.48M
Total Assets FY 2017 · Mar 31, 2018 $110.14M
Total Assets FY 2017 · Mar 31, 2017 $90.29M
Sga Expense FY 2017 · Mar 31, 2018 $4.72M
Sga Expense FY 2017 · Mar 31, 2017 $4.25M
Rd Expense FY 2017 · Mar 31, 2018 $492.08K
Rd Expense FY 2017 · Mar 31, 2017 $809.49K
Net Income FY 2017 · Mar 31, 2018 $11.74M
Net Income restated FY 2017 · Mar 31, 2017 $10.05M
Operating Income FY 2017 · Mar 31, 2018 $14.81M
Operating Income FY 2017 · Mar 31, 2017 $13.2M
Gross Profit FY 2017 · Mar 31, 2018 $25.34M
Gross Profit FY 2017 · Mar 31, 2017 $23.18M
Cost Of Revenue FY 2017 · Mar 31, 2018 $39.6M
Cost Of Revenue FY 2017 · Mar 31, 2017 $33.28M
Revenue FY 2017 · Mar 31, 2018 $64.94M
Revenue FY 2017 · Mar 31, 2017 $56.46M